Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker PPLI
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | Goldman Sachs & Co. LLC | 2.51M | 3.7% | SCHEDULE 13G/A ↗ |
| Nov 9, 2026 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | The Goldman Sachs Group, Inc. | 2.51M | 3.7% | SCHEDULE 13G/A ↗ |
| Oct 30, 2026 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | Vanguard Portfolio Management | 3.39M | 4.9% | SCHEDULE 13G/A ↗ |
| Oct 6, 2026 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | Federico Riggio | 7.86M | 11.4% | SCHEDULE 13G/A ↗ |
| Oct 6, 2026 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | Helikon Investments Limited | 7.86M | 11.4% | SCHEDULE 13G/A ↗ |
| Sep 29, 2026 | SCHEDULE 13D | PPLI People Incorporated | Jennifer Stier | 5.39M | 7.9% | SCHEDULE 13D ↗ |
| Sep 29, 2026 | SCHEDULE 13D | PPLI People Incorporated | HighSage Ventures LLC | 4.56M | 6.6% | SCHEDULE 13D ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | O. Mason Hawkins | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | Southeastern Asset Management, Inc. | 3.13M | 4.6% | SCHEDULE 13G/A ↗ |
| Aug 11, 2026 | SCHEDULE 13G | PPLI People Incorporated | Goldman Sachs & Co. LLC | 3.56M | 5.2% | SCHEDULE 13G ↗ |
| Aug 11, 2026 | SCHEDULE 13G | PPLI People Incorporated | The Goldman Sachs Group, Inc. | 3.56M | 5.2% | SCHEDULE 13G ↗ |
| Jul 9, 2026 | SCHEDULE 13G | PPLI People Incorporated | Federico Riggio | 5.65M | 7.6% | SCHEDULE 13G ↗ |
| Jul 9, 2026 | SCHEDULE 13G | PPLI People Incorporated | Helikon Investments Limited | 5.65M | 7.6% | SCHEDULE 13G ↗ |
| Jun 22, 2026 | SCHEDULE 13D/A (amended) | PPLI People Incorporated | Barry Diller | 6.59M | 8.9% | SCHEDULE 13D/A ↗ |
| Apr 29, 2026 | SCHEDULE 13G | PPLI People Incorporated | Vanguard Portfolio Management | 3.61M | 5.1% | SCHEDULE 13G ↗ |
| Mar 27, 2026 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | The Vanguard Group | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 17, 2026 | SCHEDULE 13G | PPLI People Incorporated | Aristeia Capital, L.L.C. | 5.70M | 8.0% | SCHEDULE 13G ↗ |
| Feb 13, 2026 | SCHEDULE 13G | PPLI People Incorporated | O. Mason Hawkins | 0 | 0.0% | SCHEDULE 13G ↗ |
| Feb 13, 2026 | SCHEDULE 13G | PPLI People Incorporated | Southeastern Asset Management, Inc. | 3.99M | 5.6% | SCHEDULE 13G ↗ |
| Oct 31, 2025 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | JPMorgan Chase & Co. | 3.65M | 4.9% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | Jennifer Stier | 5.39M | 7.3% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | HighSage Ventures LLC | 4.56M | 6.2% | SCHEDULE 13G/A ↗ |
| Jul 22, 2025 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | JPMorgan Chase & Co. | 6.53M | 8.8% | SCHEDULE 13G/A ↗ |
| Apr 22, 2025 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | JPMorgan Chase & Co. | 5.45M | 7.0% | SCHEDULE 13G/A ↗ |
| Apr 14, 2025 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | Jennifer Stier | 4.98M | 6.7% | SCHEDULE 13G/A ↗ |
| Apr 14, 2025 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | HighSage Ventures LLC | 4.56M | 6.1% | SCHEDULE 13G/A ↗ |
| Apr 7, 2025 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | The Vanguard Group | 7.83M | 10.1% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | Jennifer Stier | 4.81M | 6.0% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | HighSage Ventures LLC | 4.56M | 5.7% | SCHEDULE 13G/A ↗ |
| Feb 11, 2025 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | JPMorgan Chase & Co. | 4.89M | 6.0% | SCHEDULE 13G/A ↗ |
| Jan 30, 2025 | SCHEDULE 13G/A (amended) | PPLI People Incorporated | The Vanguard Group | 7.91M | 9.8% | SCHEDULE 13G/A ↗ |
| Jan 16, 2025 | SCHEDULE 13D/A (amended) | PPLI People Incorporated | Joseph M. Levin | 1.02M | 1.3% | SCHEDULE 13D/A ↗ |
| Jan 15, 2025 | SCHEDULE 13D/A (amended) | PPLI People Incorporated | Barry Diller | 7.10M | 8.1% | SCHEDULE 13D/A ↗ |
33 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:08 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances